Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02777086 · ClinicalTrials.gov registry record · NA
Sustainable HIV Risk Reduction Strategies for Probationers
A NA study, sponsored by Texas Christian University.
- Completed
- Registry status
- NA
- Development phase
- 511
- Enrollment target
NCT02777086 is a NA study that has completed, run by Texas Christian University. The registered enrollment target is 511 participants.
The verdict
NCT02777086, a NA study, has completed, sponsored by Texas Christian University.
- COMPLETED
- Registry status
- NA
- Development phase
- 511 participants
- Enrollment target
Study Summary
The purpose of the Texas Christian University (TCU) Disease Risk Reduction (DRR2) Project is to develop and test a self-administered tablet computer app, StaySafe, for probationers under community supervision that is designed to improve decision-making skills around health risk behaviors, especially involving HIV and hepatitis B \& C risks. StaySafe utilizes materials and concepts adapted from an earlier, group-based curriculum, WaySafe, designed to increase positive decision-making skills for offenders in the last phase of their prison-based substance abuse treatment before transitioning back to the community.
Interventions
- BEHAVIORAL StaySafe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 511 participants |
| Start Date | 2015-09-30 |
| Est. Completion | 2020-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02777086
The ClinicalTrials.gov registry entry for NCT02777086 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 511 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Christian University, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which StaySafe is the first listed.
NCT02777086 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02777086 about?
NCT02777086 is a clinical study titled "Sustainable HIV Risk Reduction Strategies for Probationers". The purpose of the Texas Christian University (TCU) Disease Risk Reduction (DRR2) Project is to develop and test a self-administered tablet computer app, StaySafe, for probationers under community supervision that is designed to improve decision-making skills around health risk behaviors, especially...
What is the current status of trial NCT02777086?
This trial is currently completed. It is a NA study. The enrollment target is 511 participants. The study started on 2015-09-30. Estimated completion is 2020-03-31.
What interventions are being tested in trial NCT02777086?
The interventions under investigation include: StaySafe (BEHAVIORAL).
Who is sponsoring clinical trial NCT02777086?
This trial is sponsored by Texas Christian University, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.